Skip to content

Ventrolateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of depersonalization disorder: A consecutive case series.

Emma-Louise Jay, Steffen Nestler, Mauricio Sierra, Jessica McClelland, Maria Kekic, Anthony S David

Psychiatry Research April 13, 2016 DOI: 10.1016/j.psychres.2016.04.027 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case series Randomized Case report Peer reviewed
Sample size 7
Population Adults with medication-resistant DSM-IV depersonalization disorder
Dose 1 Hz for 15 minutes per session, at 110% of resting motor threshold, up to 20 sessions
Duration 10 weeks (up to 20 sessions)
Measures Cambridge Depersonalization Scale (CDS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI)
Keywords Prefrontal cortex Humans Magnetic resonance imaging Treatment outcome Research design Adult Middle aged London Female Transcranial magnetic stimulation Case series Depersonalization disorder
Key findings Up to 20 sessions of right ventrolateral prefrontal rTMS reduced Cambridge Depersonalization Scale scores by an average of 44% (range 2-83.5%) in seven patients with medication-resistant depersonalization disorder. Two patients were full responders, four partial, and one a non-responder, with response usually occurring within the first six sessions and no significant adverse events. The authors argue that a randomized controlled trial is warranted.

Abstract

Case reports and an open trial have reported promising responses to repetitive transcranial magnetic stimulation (rTMS) to prefrontal and temporo-parietal sites in patients with depersonalization disorder (DPD). We recently showed that a single session of rTMS to the ventrolateral prefrontal cortex (VLPFC) was associated with a reduction in symptoms and increase in physiological arousal. Seven patients with medication-resistant DSM-IV DPD received up to 20 sessions of right-sided rTMS to the VLPFC for 10 weeks. Stimulation was guided using neuronavigation software based on participants' individual structural MRIs, and delivered at 110% of resting motor threshold. A session consisted of 1Hz repetitive TMS for 15min. The primary outcome measure was reduction in depersonalization symptoms on the Cambridge Depersonalization Scale (CDS). Secondary outcomes included scores on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). 20 sessions of rTMS treatment to right VLPFC significantly reduced scores on the CDS by on average 44% (range 2-83.5%). Two patients could be classified as "full responders", four as "partial" and one a non-responder. Response usually occurred within the first 6 sessions. There were no significant adverse events. A randomized controlled clinical trial of VLPFC rTMS for DPD is warranted.

Citations in the library

Explore topics